Asston Pharmaceuticals logo

Asston Pharmaceuticals

BSE SMEListed

IPO Timeline

Issue open date

9 Jul 2025

Issue close date

11 Jul 2025

UPI mandate deadline

11 Jul 2025

Allotment finalization

14 Jul 2025

Refund initiation

15 Jul 2025

Share credit

15 Jul 2025

Listing date

16 Jul 2025

Mandate end date

26 Jul 2025

Lock-in end date for anchor investors (50%)

13 Aug 2025

Lock-in end date for anchor investors (remaining)

12 Oct 2025

Grey Market Premium Trend

₹26
Current GMP
₹149
Est. Listing Price
21.1%
Est. Listing Gain
₹115 - ₹123
Price Band

GMP History

DateGMP (₹)Est. Listing Price (₹)Est. Listing Gain
15 Jul₹26₹14921.14%
14 Jul₹26₹14921.14%
13 Jul₹25₹14820.33%
12 Jul₹30₹15324.39%
11 Jul₹30₹15324.39%
10 Jul₹30₹15324.39%
9 Jul₹30₹15324.39%
8 Jul₹25₹14820.33%
7 Jul₹15₹13812.20%
6 Jul₹10₹1338.13%
5 Jul₹10₹1338.13%
4 Jul₹10₹1338.13%
3 Jul₹10₹1338.13%

Key Dates

Open
9 Jul 2025
Close
11 Jul 2025
Listing
16 Jul 2025

Quick Stats

Issue Size:27cr
Lot Size:1000 shares

Issue Details

Issue Size:27cr
Face Value:10
Listing At:BSE SME

Reservation

50%
QIB
15%
NII
35%
Retail

About the Company

Asston Pharmaceuticals manufactures pharmaceutical formulations and nutraceutical products for domestic and African markets under the “Asston” brand. Operating from its Ambernath, Maharashtra facility, the company produces tablets, capsules, oral liquids, external preparations, and oral powders with a capacity of 8-9 crore tablets per month. The company maintains separate production floors for pharmaceutical and nutraceutical products to comply with FDA and FSSAI standards. Working with five WHO-GMP certified contract manufacturers, Asston holds over 150 registered trademarks and distributes products globally, particularly in South Africa and West African regions. Founded in 2019, the company operates with over 50 team members under experienced promoters.

Strengths

  • Promoters with 30+ years’ global pharma experience drive brand and compliance.
  • Diverse product portfolio across dosage forms strengthens global market adaptability.
  • Facilities strategically located near ports and airports, enabling efficient global exports.
  • Skilled workforce ensures quality compliance across outsourced manufacturing and distribution.
  • Strong relationships with WHO-GMP certified contract manufacturers ensure quality compliance.
  • Outsourced manufacturing enables asset-light operations with minimal regulatory or capex risks.

Risks

No risks provided as of now. Please check back later.

Asston Pharmaceuticals IPO – Frequently Asked Questions

  • The price band for the Asston Pharmaceuticals IPO is set at ₹115 to ₹123 per share.
  • The Asston Pharmaceuticals IPO opens on July 9, 2025 and closes on July 11, 2025.
  • The tentative listing date for the Asston Pharmaceuticals IPO is July 16, 2025.
  • You can apply for the Asston Pharmaceuticals IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Asston Pharmaceuticals, enter lot quantity and UPI ID, then approve the mandate.
  • The lot size for the Asston Pharmaceuticals IPO is 1000 shares. Investors must apply for at least one lot (i.e., 1000 shares).